• 1
    . Buchanan WW, Tugwell P: Traditional assessments of articular diseases. Clin Rheum Dis 9: 515529, 1983
  • 2
    . Liang MG, Cullen KE, Larson MG: Measuring function and health status in rheumatic disease clinical trials. Clin Rheum Dis 9: 531539, 1983
  • 3
    . Williams HJ, Willkens RF, Samuelson CO Jr, Alarcón GS, Guttadauria M, Yarboro C, Polisson RP, Weiner SR, Luggen ME, Billingsley LM, Dahl SL, Egger MJ, Reading JC, Ward JR: Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis: a controlled clinical trial. Arthritis Rheum 28: 721730, 1985
  • 4
    . Lansbury J: Report of a three-year study on the systemic and articular indexes in rheumatoid arthritis: theoretic and clinical considerations. Arthritis Rheum 1: 505522, 1958
  • 5
    . Ritchie DM, Boyle JA, McInnes JM, Jasani MK, Dalakos TG, Grieveson P, Buchanan WW: Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med 37: 393406, 1968
  • 6
    . Smythe HA, Helewa A, Goldsmith CH: “Independent assessor” and “pooled index” as techniques for measuring treatment effects in rheumatoid arthritis. J Rheumatol 4: 144152, 1977
  • 7
    . McQuire RJ, Wright V: Statistical approaches to indices of disease activity in rheumatoid arthritis. Ann Rheum Dis 30: 574580, 1971
  • 8
    . Williams HJ, Ward JR, Reading JC, Egger MJ, Grandone JT, Samuelson CO, Furst DE, Sullivan JM, Watson MA, Guttadauria M, Cathcart ES, Kaplan SB, Halla JT, Weinstein A, Plotz PH: Low-dose D-penicillamine therapy in rheumatoid arthritis: a controlled, double-blind clinical trial. Arthritis Rheum 26: 581592, 1983
  • 9
    . Ward JR, Williams HJ, Egger MJ, Reading JC, Boyce E, Altz-Smith M, Samuelson CO Jr, Willkens RF, Solsky MA, Hayes SP, Blocka KL, Weinstein A, Meenan RF, Guttadauria M, Kaplan SB, Klippel J: Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis: a controlled clinical trial. Arthritis Rheum 26: 13031315, 1983
  • 10
    . Paulus HE, Williams HJ, Ward JR, Reading JC, Egger MJ, Coleman ML, Samuelson CO Jr, Willkens RF, Guttadauria M, Alarcón GS, Kaplan SB, MacLaughlin EJ, Weinstein A, Wilder RL, Solsky MA, Meenan RF: Azathioprine versus D-penicillamine in rheumatoid arthritis patients who have been treated unsuccessfully with gold. Arthritis Rheum 27: 721727, 1984
  • 11
    . Williams HJ, Ward JR, Dahl SL, Clegg DO, Willkens RF, Oglesby T, Weisman MH, Schlegel S, Michaels RM, Luggen ME, Polisson RP, Singer JZ, Kantor SM, Shiroky JB, Small RE, Gomez MI, Reading JC, Egger MJ: A controlled trial comparing sulfasalazine, gold sodium thiomalate, and placebo in rheumatoid arthritis. Arthritis Rheum 31: 702713, 1988
  • 12
    . Dwosh IL, Stein HB, Urowitz MB, Smythe HA, Hunter T, Ogryzlo MA: Azathioprine in early rheumatoid arthritis: a comparison with gold and chloroquine. Arthritis Rheum 20: 685692, 1977
  • 13
    . Hoh K-F, Dwosh IL, Ford PM, Anastassiades TP, Kelley HG: Drug-related disease remissions in rheumatoid arthritis (abstract). Arthritis Rheum 24 (suppl 4): S72, 1981
  • 14
    . Currey HLF, Harris J, Mason RM, Woodland J, Beveridge T, Roberts CJ, Vere DW, Dixon AStJ, Davies J, Owen-Smith B: Comparison of azathioprine, cyclophosphamide, and gold in treatment of rheumatoid arthritis. Br Med J 3: 763766, 1974
  • 15
    . Kirwan JR, Currey HLF: Rheumatoid arthritis: disease-modifying anti-rheumatic drugs. Clin Rheum Dis 9: 581599, 1983
  • 16
    . Paulus HE: Pilot efficacy studies—identifying their role in drug development and rationale for their use: the Paulus model, Proceedings: Early Decisions in DMARD Development. Atlanta, Arthritis Foundation, 1989